Simulations Plus Inc Cash Flow Conversion Efficiency

Latest as of May 2026: 0.074x

Simulations Plus Inc cash flow conversion efficiency. Based on the latest financial reports, Simulations Plus Inc (SLP) has a cash flow conversion efficiency ratio of 0.074x as of May 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($10.25 Million) by net assets ($139.04 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Simulations Plus Inc (1996–2025)

Cash flow conversion efficiency of Simulations Plus Inc from 1996 to 2025. This chart illustrates how Simulations Plus Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Simulations Plus Inc stock quote for real-time trading data and today's change.

Simulations Plus Inc Cash Flow Conversion Ratio Explained

Simulations Plus Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Simulations Plus Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Simulations Plus Inc ranked by their cash flow conversion efficiency. Also see Simulations Plus Inc market cap and net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
RattanIndia Enterprises Limited
NSE:RTNINDIA
-0.203x
LB Foster Company
NASDAQ:FSTR
0.100x
Changzhou Langbo Seal Polytron Technologies Co Ltd Class A
SHG:603655
0.016x
MCLON JEWELLERY Co.Ltd.
SHE:300945
N/A
Ozak Gayrimenkul Yatirim Ortakligi AS
IS:OZKGY
0.000x
Symphony Limited
NSE:SYMPHONY
0.191x
I.C.C. International Public Company Limited
BK:ICC
0.003x
Net Holding AS
IS:NTHOL
0.017x

Annual Cash Flow Conversion Efficiency for Simulations Plus Inc (1996–2025)

The table below shows the annual cash flow conversion efficiency of Simulations Plus Inc from 1996 to 2025. Review SLP free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-08-31 $124.80 Million $18.13 Million 0.145x +98.92%
2024-08-31 $182.43 Million $13.32 Million 0.073x -43.20%
2023-08-31 $170.03 Million $21.86 Million 0.129x +28.00%
2022-08-31 $178.25 Million $17.90 Million 0.100x -13.30%
2021-08-31 $165.78 Million $19.20 Million 0.116x +65.64%
2020-08-31 $156.04 Million $10.91 Million 0.070x -77.36%
2019-08-31 $37.68 Million $11.64 Million 0.309x +6.16%
2018-08-31 $31.92 Million $9.29 Million 0.291x +9.15%
2017-08-31 $25.80 Million $6.88 Million 0.267x +11.89%
2016-08-31 $22.73 Million $5.42 Million 0.238x -34.79%
2015-08-31 $19.53 Million $7.13 Million 0.365x +6.26%
2014-08-31 $15.44 Million $5.31 Million 0.344x +91.08%
2013-08-31 $14.24 Million $2.56 Million 0.180x -28.00%
2012-08-31 $15.14 Million $3.78 Million 0.250x +0.29%
2011-08-31 $14.04 Million $3.50 Million 0.249x +11.86%
2010-08-31 $13.05 Million $2.91 Million 0.223x -5.50%
2009-08-31 $10.57 Million $2.49 Million 0.236x -5.64%
2008-08-31 $9.92 Million $2.48 Million 0.250x -35.39%
2007-08-31 $7.66 Million $2.96 Million 0.387x +90.98%
2006-08-31 $5.67 Million $1.15 Million 0.202x -31.56%
2005-08-31 $4.86 Million $1.44 Million 0.296x +128.72%
2004-08-31 $4.45 Million $575.05K 0.129x -21.73%
2003-08-31 $3.28 Million $541.85K 0.165x +14.24%
2002-08-31 $767.88K $111.07K 0.145x -85.99%
2001-08-31 $282.97K $292.10K 1.032x +239.14%
2000-08-31 $486.07K $147.95K 0.304x +152.85%
1999-08-31 $740.66K $89.16K 0.120x +111.96%
1998-08-31 $1.28 Million $-1.29 Million -1.007x -141.11%
1997-08-31 $3.35 Million $-1.40 Million -0.418x -183.51%
1996-08-31 $200.00K $100.00K 0.500x --

About Simulations Plus Inc

NASDAQ:SLP USA Health Information Services
Market Cap
$374.16 Million
Market Cap Rank
#13419 Global
#3273 in USA
Share Price
$18.50
Change (1 day)
+0.00%
52-Week Range
$11.36 - $20.84
All Time High
$87.82
About

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans… Read more